Comparison of Blood Glucose Testing Using Reagent Strips With and Without a Meter (Chemstrips bG and Dextrostix/Dextrometer)

BACKGROUND: Portable blood glucose meters are the main method for detecting the blood glucose status of clinical patients. OBJECTIVE: To investigate the accuracy of detecting blood glucose in haemodialysis patients by sampling two blood glucose meters through the haemodialysis line. METHODS: Convenient sampling was used to select 80 patients with maintenance haemodialysis. The patients were sampled through the arterial end of the haemodialysis line within three minutes of being put on the machine. One specimen was tested by glycemeter1, which can identify the type of blood in the arteries and veins, and glycemeter2, which can only detect blood glucose in the capillaries for bedside blood glucose testing. The other specimen was sent to the laboratory biochemical analyser for blood glucose testing. RESULTS: When the blood glucose value of the first blood glucose meter (No. 1) was compared with the laboratory biochemical analyser, the correlation coefficient was r = 0.805 (p < 0.05), the out of value of the first blood glucose meter accounted for 4.4%, and the consistency reached 95% (p < 0.05). When the blood glucose value of the second blood glucose meter (No. 2) was compared with the laboratory biochemical analyser, the correlation coefficient was r = 0.800 (p < 0.05), the out of value of the second blood glucose meter accounted for 4.4%, and the consistency reached 95% (p < 0.05). CONCLUSIONS: For patients with maintenance haemodialysis, the blood glucose values detected by the two bedside blood glucose meters using arteriovenous mixed blood in the pipeline do not affect the accuracy and can respond more realistically.

Download Full-text

Non-invasive blood glucose testing: the horizon

Practical Diabetes ◽

10.1002/pdi.2062 ◽

2016 ◽

Vol 33 (9) ◽

pp. 313-315a ◽

Cited By ~ 1

Author(s):

Steve Chaplin

Keyword(s):

Blood Glucose ◽

Glucose Testing ◽

Non Invasive ◽

Blood Glucose Testing

Download Full-text

Automated Diabetes Testing Device for the One-Armed/Disabled Patient

ASME 2011 Summer Bioengineering Conference, Parts A and B ◽

10.1115/sbc2011-53821 ◽

2011 ◽

Author(s):

Ali Abdallah ◽

Brandon Heid ◽

Hajra Khan ◽

Nigil Valikodath

Keyword(s):

Blood Glucose ◽

Glucose Level ◽

Motor Coordination ◽

The United States ◽

Fine Motor ◽

Diabetic Patients ◽

Testing Device ◽

Older Individuals ◽

Glucose Testing ◽

Blood Glucose Testing

We were approached by an amputee diabetic to build a device that could test blood sugar with the use of only one arm. Originally, this product was client based only. It was designed for an elderly diabetic amputee such that the device would allow him to single-handedly manage his blood glucose testing without any extra assistance from other persons. Although this was originally a client-specific device, it is expected to have a broader market based on the prevalence of arm amputations among the diabetic patient population. Statistics reveal that over 80,000 amputations are performed each year in the United States on people with diabetes. [1] The target audience is also intended for older individuals who suffer from having limited fine motor coordination due to conditions such as arthritis. Diabetic patients must test their glucose level several times a day, and therefore it is absolutely critical to have a glucose-testing device that allows a user to test his or her glucose-level with no trouble. This device would provide these diabetic patients with access to a more convenient and user-friendly system that would allow an individual to test his or her blood glucose level with ease.

Download Full-text

The National Diabetes Education Program's “Control Your Diabetes. For Life.” Campaign: Design, Implementation, and Lessons Learned

Social Marketing Quarterly ◽

10.1080/15245000701678453 ◽

2007 ◽

Vol 13 (4) ◽

pp. 65-82 ◽

Cited By ~ 16

Author(s):

Joanne Gallivan ◽

Mimi Lising ◽

Neyal J. Ammary ◽

Rachel Greenberg

Keyword(s):

Blood Glucose ◽

Social Marketing ◽

Glucose Control ◽

Diabetes Education ◽

Blood Glucose Control ◽

Lessons Learned ◽

Awareness Campaigns ◽

Glucose Testing ◽

Blood Glucose Testing ◽

National Partnership

The National Diabetes Education Program (NDEP) is a federally sponsored national partnership including government, nonprofit, professional, and private sector organizations. The NDEP uses social marketing principles and processes to develop and implement awareness campaigns and educational activities to improve the treatment and health status of people with diabetes. Co-sponsored by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), NDEP launched its “Control Your Diabetes. For Life.” awareness campaign in 1998. The campaign was designed to educate the millions of Americans with diabetes and their social supporters about the seriousness of diabetes, ways to control the disease, and the benefits of good glucose control. The NDEP conducted extensive audience research and applied behavior change theories and the social marketing framework to design, implement, and evaluate the campaign. From 1998 to 2003, the campaign achieved at least 700 million media impressions with its culturally appropriate television and radio public service announcements, print ads, and newspaper and magazine stories. In addition, over half of people with diabetes indicated awareness of the campaign and NDEP has tracked positive trends in practice of blood glucose testing and awareness of the A1C (also known as the hemoglobin A1C), the best measure of blood glucose control, since the campaign's launch.

Download Full-text